367 related articles for article (PubMed ID: 2991338)
1. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
Vanderwel M; Haslam RJ
J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
Bowen R; Haslam RJ
J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
[TBL] [Abstract][Full Text] [Related]
4. Modulatory role of cyclic AMP in the release of platelet-activating factor from human polymorphonuclear leucocytes.
Alonso F; Sánchez-Crespo M; Mato JM
Immunology; 1982 Mar; 45(3):493-500. PubMed ID: 6277775
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
[TBL] [Abstract][Full Text] [Related]
7. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
8. Functional pool of cyclic adenosine 3',5'-monophosphate in rabbit platelets.
Hashimoto S
Thromb Haemost; 1983 Feb; 49(1):8-12. PubMed ID: 6302940
[TBL] [Abstract][Full Text] [Related]
9. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
Thiemermann C; Lidbury PS; Thomas GR; Vane JR
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
[TBL] [Abstract][Full Text] [Related]
12. The increased sensitivity of platelets to prostacyclin in marathon runners.
Dix CJ; Hassall DG; Bruckdorfer KR
Thromb Haemost; 1984 Jul; 51(3):385-7. PubMed ID: 6093280
[TBL] [Abstract][Full Text] [Related]
13. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
Salzman EW; Levine L
J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
[TBL] [Abstract][Full Text] [Related]
14. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
15. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
Hashimoto S; Shibata S; Kobayashi B
Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-aminoadamantanes on adenine nucleotide and serotonin storage in blood platelets.
Wesemann W; Muschalek G; Stöltzing H; von Pusch I; Paul N
Eur J Cell Biol; 1981 Dec; 26(1):158-67. PubMed ID: 7327177
[TBL] [Abstract][Full Text] [Related]
17. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
Menter DG; Onoda JM; Moilanen D; Sloane BF; Taylor JD; Honn KV
J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692
[TBL] [Abstract][Full Text] [Related]
19. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
